Cargando…
Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816843/ https://www.ncbi.nlm.nih.gov/pubmed/36618803 http://dx.doi.org/10.21037/atm-2022-70 |
| _version_ | 1784864630556852224 |
|---|---|
| author | Zhou, Yitian Lauschke, Volker M. |
| author_facet | Zhou, Yitian Lauschke, Volker M. |
| author_sort | Zhou, Yitian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9816843 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98168432023-01-07 Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results Zhou, Yitian Lauschke, Volker M. Ann Transl Med Editorial Commentary AME Publishing Company 2022-12 /pmc/articles/PMC9816843/ /pubmed/36618803 http://dx.doi.org/10.21037/atm-2022-70 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Zhou, Yitian Lauschke, Volker M. Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results |
| title | Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results |
| title_full | Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results |
| title_fullStr | Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results |
| title_full_unstemmed | Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results |
| title_short | Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results |
| title_sort | should we test for slco1b1 genotype before prescribing statins?—a discussion of clinical trial results |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816843/ https://www.ncbi.nlm.nih.gov/pubmed/36618803 http://dx.doi.org/10.21037/atm-2022-70 |
| work_keys_str_mv | AT zhouyitian shouldwetestforslco1b1genotypebeforeprescribingstatinsadiscussionofclinicaltrialresults AT lauschkevolkerm shouldwetestforslco1b1genotypebeforeprescribingstatinsadiscussionofclinicaltrialresults |